on BOIRON (EPA:BOI)
Evolution of Governance at Laboratoires BOIRON
On July 3rd, 2024, the Board of Directors of Laboratoires BOIRON met under the chairmanship of Thierry Boiron to enact a significant evolution in the group's governance.
Thierry Boiron has been appointed CEO, succeeding Valérie Lorentz-Poinsot, who has resigned from her position as Director of the board. Anabelle Flory-Boiron, previously with the company for 19 years and a Director since 2020, has been named Chairman of the Board of Directors, replacing Thierry Boiron.
Thierry Boiron expressed gratitude to Valérie Lorentz-Poinsot for her efforts and highlighted the initiation of a new development strategy during her tenure. He emphasized his commitment to leading an ambitious and challenging new development cycle as CEO.
Anabelle Flory-Boiron expressed her enthusiasm for continuing the family legacy in her new role. She confirmed the company's dedication to providing homeopathy and other health solutions worldwide, aiming to enhance a humane, efficient, and sustainable healthcare system.
R. E.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all BOIRON news